ARTICLE | Clinical News
Adagio: Phase I/II data
August 19, 2013 7:00 AM UTC
Preliminary data from the Phase I/II Samba 01 trial in 12 Type I diabetics showed that Adagio was safe and well tolerated and did not lead to coughing. Dance Biopharm said Adagio delivered insulin con...